IMO, it feels like CYDY is more focused on selling a stock while HGEN is focused on selling a drug. Durrant is the under-promise, over deliver type. Nadar has built up some very HIGH hopes, with way less substance to work with. If CYDY had the NIAID & OWS relationship HGEN has, you can guarantee he would be PRing something about that EVERYDAY. The difference in market cap and daily volume tells the story perfectly. PR fluff pieces are for short term results, science & a good product will bring the long term results.
News 
Market Data 
Discover 
AI
